BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180517T120000
DTEND;TZID=America/New_York:20180517T130000
DTSTAMP:20260618T050030
CREATED:20180517T160000Z
LAST-MODIFIED:20190307T184247Z
UID:10000882-1526558400-1526562000@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, Sascha Tuchman and Koyal Jain\, "Amyloidosis\, Cyanide\, Myeloma and Ethanol: Conceptualizing Renal Diseases Caused by Monoclonal Gammopathies"
DESCRIPTION:Monoclonal gammopathies are a group of plasma cell or B-cell disorders including true cancers such as multiple myeloma or “sort-of cancers” such as light chain amyloidosis. These disorders in many cases cause no injury to a person (i.e.\, monoclonal gammopathy of undetermined significance [MGUS]) but when they do cause injury\, the pattern of injury can be quite varied and often includes the kidneys. Monoclonal gammopathy of renal significance (MGRS) is a recently described category of nephrotroxic monoclonal gammopathies that arise in the absence of an overt hematologic malignancy. Monoclonal gammopathies overall have been increasingly recognized as a cause of renal failure. Over 660\,000 Americans have kidney failure\, and early recognition of the etiology of kidney disease can prevent progression to end-stage kidney disease through aggressive interventions\, such as chemotherapy in proven cases of multiple myeloma or MGRS. The management of these patients requires close collaboration between nephrologists and oncologists. In this presentation\, we will be focusing on the wide spectrum of diseases associated with nephrotoxic plasma cell disorders\, with a focus on how to conceptualize them clinically. \nSascha Tuchman is a UNC Comprehensive Cancer Center member and Associate Professor of Medicine. Dr. Tuchman’s research has a special focus on amyloidosis and multiple myeloma.  \nKoyal Jain is an Assistant Professor of Medicine in the Nephrology division. She specializes in acute kidney injury and chronic kidney disease\, dialysis management\, high blood pressure management\, abnormalities of electrolytes like sodium\, potassium\, calcium\, and glomerular diseases.
URL:https://www.med.unc.edu/medicine/event/may-17/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/sascha-tuchman.jpeg
END:VEVENT
END:VCALENDAR